Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)

Organon

Status and phase: Completed; Phase 3

Conditions: Osteoarthritis

Treatments: Drug: Comparator: Diclofenac sodium; Drug: MK0663, etoricoxib

Study type: Interventional

Funder types: Industry

Identifiers

NCT00092703

0663-061

2004_052

Details and patient eligibility

About

The purpose of this study is to compare the gastrointestinal tolerability of an investigational drug to an approved drug in the treatment of osteoarthritis during one year treatment period.

Full description

The duration of treatment is 12 months.

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Osteoarthritis of the knee, hip, hand or spine which requires the use of medications for pain relief

Exclusion criteria

• Known allergies to the study drugs

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind